Physician profile
George Noumi
NPI 1215001375
$4,836.07
in general payments reported to CMS, 2019-2025
25 companies · $426 in 2025
The $426 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $881 · 2020: $407 · 2021: $1,109 · 2022: $616 · 2023: $436 · 2024: $961 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,753 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,753.03 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,529.64 | 2019-2023 | |
| Myovant Sciences INC. | $462.83 | 2021-2022 | |
| Astellas Pharma US INC | $445.45 | 2022-2025 | Veozah, Cresemba |
| Hologic Sales and Service, LLC | $311.61 | 2021-2024 | Novasure, Acessa Provu System, Omni Hysteroscope |
| Glaxosmithkline, LLC. | $250.00 | 2024 | Arexvy, Shingrix |
| Aspira Women'S Health INC | $228.63 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $200.36 | 2023-2025 | Myfembree |
| Baxter Healthcare | $174.62 | 2020-2024 | Starling System |
| Evofem Biosciences, INC. | $168.33 | 2021 | |
| Daiichi Sankyo INC. | $167.80 | 2019-2021 | |
| Davol INC. | $154.50 | 2023 | |
| Novo Nordisk INC | $125.00 | 2024 | Wegovy |
| Agile Therapeutics, INC. | $124.55 | 2021 | |
| Organon LLC | $123.32 | 2025 | Jada System |
| Channel Medsystems, INC. | $76.38 | 2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $48.09 | 2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $47.89 | 2025 | |
| Coopersurgical, INC. | $37.40 | 2022-2023 | Summit Doppler |
| Lupin INC. | $37.13 | 2020 | |
| Ethicon US, LLC | $28.12 | 2021 | |
| Shield Therapeutics INC | $26.83 | 2024 | |
| Avion Pharmaceuticals | $19.14 | 2022 | |
| Mission Pharmacal Company | $19.12 | 2019 | |
| Vertical Pharmaceuticals, LLC | $14.83 | 2019 | |
| Sanofi Pasteur INC. | $14.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Noumi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.